Establishment and Characterization of a Bladder Cancer Cell Line With Enhanced Doxorubicin Resistance by Mevalonate Pathway Activation

Tumor Biology- United States

doi 10.1007/s13277-014-2959-9

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search